glp-1 news today 2025 november 5 In U.S., Usage Reaches New High Novo Nordisk, Lilly strike deal

As recently described in a brief communication in Gastroenterology , these patients surprisingly experienced complete remission of their bile acid diarrhea, in addition to the expected glucose- and body weight-lowering effects of liraglutide

doi: 10.3390/brainsci15050480, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 51

GLP-1 receptor agonists are approved for conditions such as Type 2 diabetes and certain weight-related indications, not for addiction treatment

Gastroparesis patients endure persistent nausea, severe abdominal cramping, repeated vomiting episodes disrupting daily activities, and malnutrition from inability to properly digest food